Expression of Annexin A1 and UCH-L1 in central nervous system neuroepithelial tumors

1. Pan E, Prados MD. Primary neoplasm of the central nervous system. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E, editors. Holland-Frei Cancer Medicine 6th ed. Ontario: BC Decker; 2003. p. 879-900.Search in Google Scholar

2. Frosch MP, Antony DC, Girolami UD. The central nervous system. In: Kumar V, Abbas AK, Fauston N, editors. Robbins & Cotran Pathologic Basis of Disease 7th ed. Pennsylvania: Elsevier Inc; 2005. p. 1401-14.Search in Google Scholar

3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol. 2007; 114:97-109.10.1007/s00401-007-0243-4Open DOISearch in Google Scholar

4. Mckeever PE. Insights about brain tumors gained through immunohistochemistry and in situ hybridization of nuclear and phenotypic markers. J Histochem Cytochem. 1998; 46:585-94.10.1177/002215549804600504Open DOISearch in Google Scholar

5. Chen D, Chen F, Yang X, Lu X, Zu Z, Pan J, et al. Identification of prohibitin as a potential biomarker for colorectal carcinoma base on proteomics technology. Int J oncol. 2010; 37:355-65.Search in Google Scholar

6. Wang J, Dong Y, Wang X, Ma H, Sheng Z, Li G, et al. Expression of EphA1 in gastric carcinoma is associated with metastasis and survival. Oncol Rep. 2010; 24: 1577-84.Search in Google Scholar

7. Ahn SH, Sawada H, RO JY, Nicolson GL. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissue. Clin Exp Metastasis. 1997; 15:151-6.10.1023/A:1018452810915Open DOISearch in Google Scholar

8. Chen G, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JM, et al. Proteomics analysis of lung adenocarcinoma: identification of highly expressed set of protein in tumors. Clin Cancer Res. 2002; 7: 2298-305.Search in Google Scholar

9. De Bont JM, den Boer ML, Kros JM, Pasier MM, Reddingius RE, Smitt PA, et al. Identification of novel biomarkers in pediatric primitive neuroectodermal tumor and ependymomas by proteome-wide analysis. J Neuropathol Exp Neurol. 2007; 66:505-16.10.1097/01.jnen.0000240475.35414.c3Open DOISearch in Google Scholar

10. Park CK, Jung JH, Park SH, Jung HW, Cho BK. Multifarious proteomics signatures and regional heterogeneity in glioblastomas. J Neurooncol. 2009; 94:31-9.10.1007/s11060-009-9805-8Open DOISearch in Google Scholar

11. Schittenhelm J, Trautmann K, Tabatabai G, Hermann C, Meyermann R, Beschorner R. Comparative analysis of annexin-1 in neuroepithelial tumors show altered expression with the grade of malignancy but is not associated with survival. Mod Pathol. 2009; 22: 1600-11.10.1038/modpathol.2009.132Open DOISearch in Google Scholar

12. Johnso MD, Kamso-Pratt J, Pepsinsky RB, Whetsel WO Jr. Lipocortin in central and peripheral nervous system glial tumor. Hum Pathol. 1989; 20:772-6.10.1016/0046-8177(89)90071-3Open DOISearch in Google Scholar

13. Zhang Y, Li Q, Zhu F, Cui J, Li K, Li Q, et al. Subcellular localization of APMCF I and its biological significance of expression pattern in normal and malignant human tissue. J Exp Clin Cancer Res. 2009; 28:111-6.10.1186/1756-9966-28-111Open DOISearch in Google Scholar

14. Lim LH, Perraiz S. Annexin 1: The new face of an old molecule. FASEB J. 2007; 21:968-75.10.1096/fj.06-7464revOpen DOISearch in Google Scholar

15. Allderidge LC, Bryant CE. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of ERK1/ 2 MAPK signal. Exp Cell Res. 2003; 290:93-107.10.1016/S0014-4827(03)00310-0Search in Google Scholar

16. D’ Acquisto F, Merghani A, Lecona E, Rosignoli G, Raza K, Buckley CD, et al. Annexin-1 modulates T-cell activation and differentiation. Blood. 2007; 109: 1090-102.10.1182/blood-2006-05-022798Search in Google Scholar

17. Solito E, de Coupade C, Canaider S, Goulding NJ, Perretti M. Transfection of Annexin 1 in monocytic cell produces a high degree of spontaneous and stimulate apoptosis associated with caspase-3 activation. Br J Pharmacol. 2001; 133:217-28.10.1038/sj.bjp.0704054Open DOISearch in Google Scholar

18. Falini B, Tiacci E, Liso A, Basso K, Sabattini E, Pacini R, et al. Simple diagnostic assay for hairy cell leukemia by immunohistochemical detection of Annexin A1 (ANXA1). Lancet. 2004; 363:1869-70.10.1016/S0140-6736(04)16356-3Open DOISearch in Google Scholar

19. Masaki T, Tokuda M, Ohnishi M, Watanabe S, Fujimura T, Miyamoto K, et al. Enhance expression of protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology. 1996; 24:72-81.Search in Google Scholar

20. Sinha P, Hutter G, Kottgen E, Dietel M, Schadendorf D, Larg H. Increased expression of annexin l and thioredoxin detect by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells. J Biochem Biophys Methods. 1998; 37: 105-16.10.1016/S0165-022X(98)00020-7Open DOISearch in Google Scholar

21. Bai XF, Ni XG, Zhao P, Lui SM, Wang HX, Gou B, et al. Over-expression of Annexin1 in pancreatic cancer and its clinical significance. World J Gastroenterol. 2004; 10:1466-70.10.3748/wjg.v10.i10.1466Open DOISearch in Google Scholar

22. Xia SH, Hu LP, Hu H, Ying WT, Xu X, Cai Y, et al. Three isoform of Annexin l are preferentially expressed in normal esophageal epithelial but down regulate in esophageal squamous cell carcinomas. Oncogene. 2002; 21:6641-8.10.1038/sj.onc.1205818Open DOISearch in Google Scholar

23. Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstien DK. Dysregulation of annexin 1 protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin cancer Res. 2002; 8:117-23.Search in Google Scholar

24. Garcia Pedrero JM, Fernandez MP, Morgan RO, Herrero ZA, Gonzailez MV, Suazez NC, et al. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pahtol. 2004; 164:73-9.10.1016/S0002-9440(10)63098-2Search in Google Scholar

25. Vishwanatha JK, Salazer E, Gopalakrishnan VK. Absence of annexin l expression in B-cell non- Hodgkin’s lymphomas and cell lines. BMC cancer. 2004; 4:8-16.10.1186/1471-2407-4-838523615070421Open DOISearch in Google Scholar

26. Solito E, Mcarther S, Christian H, Gavin F, Buckingham JC, Gillines GE. Annexin A1 in the brain - undiscovered roles? Trends Phamacol Sci. 2008; 29:135-42.Search in Google Scholar

27. Johnson MD, Gray ME, Pepinsky RB, Stahlman MT. Lipocortin-1 immunoreactivity in human pituitary gland. J Histochem Cytochem. 1990; 38:1814-45.10.1177/38.12.21477092147709Open DOISearch in Google Scholar

28. Probst-Cousin S, Kowolik D, Kuchelmeister K, Kayser C, Neundorfer B, Heuss D. Expression of Annexin-1 in multiple sclerosis plaques. Neuropathol Appl Neurobiol. 2002; 28:292-300.10.1046/j.1365-2990.2002.00396.x12175341Open DOISearch in Google Scholar

29. Liu Y, Fallow L, Lashuel HA, Lui Z, Lansbury PT Jr.Search in Google Scholar

The UCH-L1 gene encodes two opposing enzimatic activites that affct alpha-Synuclein degradation and Parkinson’s disease susceptibility. Cell. 2002; 111: 209 -18.10.1016/S0092-8674(02)01012-7Search in Google Scholar

30. Rolen U, Freda E, Xie J, Pfirrmann T, Frisan T, Masucci MG. The ubiquitin c-terminal hydrolase UCH-L1 regulates B-cell proliferation and integrin activation. J cell Mol Med. 2009; 13:1666-78.10.1111/j.1582-4934.2008.00501.x651238920187292Open DOISearch in Google Scholar

31. Gavioli R, Frisan T, Vertuani S, Bornkamm GW, Masucci MG. c-myc overexpression activation alternative pathways for intracellular proteolysis in lymphoma cells. Nat Cell Biol. 2001; 3:283-8.10.1038/3506007611231578Open DOISearch in Google Scholar

32. Tezel E, Hibi k, Nakasha T, Nakao A. PGP 9.5 as a prognostic factor in pancreatic cancer. Clin Cancer Res. 2006; 12:4764 -7.Search in Google Scholar

33. Takase T, Hibi K, Yamazaki T, Nakayama H, Taguchi M, Kasia Y, et al. PGP9.5 Overexpression in esophageal squamous cell carcinoma. Hepatogastroenterology. 2003; 50:1278-80.Search in Google Scholar

34. Okochi-Takada E, Nakazawa K, Wakabayashi M, Mori A, Ichimura S, Yasugi T, et al. Silencing of the UCHL1 gene in human colorectal and ovarian cancers. Int J cancer. 2006; 119:1338-44.10.1002/ijc.2202516642472Search in Google Scholar

35. Takumaru Y, Yamashita K, Osada M, Nomoto S, Sun D, Xiao Y, et al. Inverse correlation between cyclin A1 Hypermethylation and P53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Cancer Res. 2004; 64:5982-7.10.1158/0008-5472.CAN-04-099315342377Search in Google Scholar

36. Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, et al. Epigenetic identification of ubiquitin carboxylterminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumor. Hepatology. 2008; 48:508-18.10.1002/hep.2234318666234Open DOISearch in Google Scholar

37. Day IN, Thomson RJ. UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein. Neurobiology. 2010; 90:327-62.Search in Google Scholar

38. Sesuie R, Wada K. The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem Int. 2007; 51:105-11.10.1016/j.neuint.2007.05.00717586089Search in Google Scholar